Dermatology Times Staff

Experts discuss how clinicians translate clinical trial results into practical treatment decisions for alopecia areata.

Panelists discuss the role of communication, follow-up, and safety monitoring in optimizing long-term biologic therapy outcomes.

Panelists discuss the role of communication, follow-up, and safety monitoring in optimizing long-term biologic therapy outcomes.

Experts discuss why alopecia areata should be viewed as a systemic condition with psychosocial consequences beyond visible hair loss.

Experts discuss how clinicians identify the right moment to transition from conventional therapy to biologic treatment in patients with hidradenitis suppurativa (HS).

The reimagined Don’t Be Rash podcast positions industry leaders at the center of pediatric skin conversations.

In part 3 of this supplement, experts discuss treatment options for adults with hormonal pattern acne and PIH.

In part 3 of this Case-Based Roundtable supplement, experts discuss psoriatic therapies for hair-baring areas.

In part 2 of this supplement, experts discuss therapies for inflammatory acne

In part 2 of this Case-Based Roundtable supplement, experts discuss therapeutic options for psoriasis when considering involvement of special areas.

In part 1 of this supplement, experts discuss current and emerging treatments for patients, considering lifestyle choices.

In part 1 of this Case-Based Roundtable supplement, experts discuss biologic treatment options for psoriasis and balancing efficacy with patient needs.

Selected pieces will be featured in Dermatology Times’ year-end and early-2026 coverage.

In a recent Dermatology Times custom video series, Zoe Diana Draelos, MD, and Cheri Frey, MD, discussed evidence-based cleansing and moisturizing practices for sensitive skin.

Cutaneous immune-related adverse events (cirAEs) from immune checkpoint inhibitors (ICIs) show distinct immune profiles from classic skin conditions.

In part 3 of this Frontline Forum supplement, experts discuss surgical innovations in HS, setting treatment expectations, and more.

In part 2 of this Frontline Forum supplement, experts discuss current and emerging treatments, digital tools and supports, and more.

In part 1 of this Frontline Forum supplement, experts discuss the burden of HS, reducing diagnostic delays, and more.

Chronic hand eczema poses diagnostic and treatment challenges due to its multifaceted etiology. New therapies like JAK inhibitors offer hope.

Christopher Bunick, MD, PhD, is an associate professor of dermatology and physician-scientist at Yale School of Medicine in New Haven, Connecticut.

Experts in the field shared insights with Dermatology Times on what they're looking forward to most in the new year.

Experts in the field shared insights with Dermatology Times on what they found most innovative, educational, and helpful in the past year.

Ahead of 2025, Dermatology Times wants to know what conferences and meetings you plan to attend in early 2024. Share your thoughts with us by December 10.

A message of gratitude to the dermatology community for 45 years of collaboration, insights, and advancing care worldwide.

In a Dermatology Times Case-Based Roundtable event, Heather Woolery-Lloyd, MD, shared pearls for challenging acne cases.

In a Dermatology Times Case-Based Roundtable event, James Del Rosso, DO, shared pearls for challenging acne cases.

Share your insights, challenges, and clinical success stories while connecting with colleagues in a new Dermatology Times forum.

In a Dermatology Times Case-Based Roundtable event, Hilary Baldwin, MD, shared pearls for challenging acne cases.

Shanna Miranti, MMS, PA-C, reviews 2 patient cases of pseudo acne fulminans, offering perspectives on treatment and management strategies.